Stay updated on Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page
- Check6 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a small software or content-management update to the page.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedFooter now shows Revision: v3.5.3, replacing v3.5.2, indicating a software version update. This change does not affect trial data, eligibility criteria, or page content.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.5.2 added; Revision: v3.5.0 removed.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Hepatocellular carcinoma as a disease tag and a new Genetic and Rare Diseases Information Center resource link. Updated page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check70 days agoChange DetectedWebsite revision updated from v3.4.2 to v3.4.3; no visible changes to the Study Details page.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision note v3.4.2 was added and older maintenance notes (v3.4.1) were removed, along with a government-funding status notice. This update affects only site metadata and does not alter study details or results.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page.